Axsome's AXS-02 gets Fast Track for complex regional pain

FDA granted Fast Track designation to AXS-02 from Axsome Therapeutics Inc. (New York, N.Y.) to treat complex regional pain syndrome (CRPS). The oral, non-opioid candidate has Orphan designation in the...